SITE007-0151

SITE007 (JPN) › SITE007-0151

SITE007-0151

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2026-02-26

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-02-24 (study day 170); relationship: not assessed

mild assessed

Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-01-12 (study day 127); relationship: not assessed

mild assessed

Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-11-27 (study day 81); relationship: not assessed

moderate assessed

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-17 (study day 40); relationship: RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.